세계의 대동맥류 시장 보고서(2025년)
Aortic Aneurysm Global Market Report 2025
상품코드 : 1821714
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

대동맥류 시장 규모는 앞으로 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 10.2%를 나타내 59억 8,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 세계 고령화 인구 증가, 심혈관질환의 이환율 증가, 치료방법의 진보, 유전적 소인의 인식, 헬스케어 인프라의 개발에 기인하고 있습니다. 예측 기간의 주요 동향은 차세대 스텐트 이식편 개발, 원격 모니터링을 위한 기술 통합, 복부 대동맥류(AAA)의 유행, 연구 개발의 공동 연구 등을 포함합니다.

향후 5년간의 성장률 10.2%라고 하는 예측은 전회의 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 상승은 이탈리아와 스위스에서 조달한 혈관내 스텐트 이식편 및 혈관내 초음파 시스템의 비용을 밀어 올리고, 선택적 복구 지연을 악화시키고, 심장혈관 부문의 비용을 증가시킴으로써 미국의 혈관 수술에 부담을 줄 가능성이 높습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

예상되는 알코올과 담배 사용량 증가는 향후 대동맥류 시장을 견인할 것으로 예측됩니다. 알코올과 니코틴을 포함한 담배 제품도 신체의 중추 신경계에 영향을 미치는 정신 작용 물질입니다. 이러한 물질의 소비 증가는 대동맥류의 주요 원인이 되었습니다. 스위스에 본부를 두고 있는 국제 공중보건기구인 세계보건기구(WHO)의 2022년 5월 보고서에 따르면 연간 추정 300만명의 사망이 알코올 섭취로 인한 반면 700만명의 사망이 담배 사용으로 세계적으로 발생하고 있습니다. 또한 20-39세 사망자의 약 13.5%가 음주와 관련되어 있습니다. 2021년 미국 국립공중보건기구인 질병대책예방센터(CDC)는 18세 이상의 미국 성인의 11.5%가 담배를 피우고 있으며 그 수는 2,830만 명에 달한다고 보고했습니다. 따라서 알코올과 담배 소비 증가는 대동맥류 시장 성장 촉진요인이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

An aortic aneurysm refers to a balloon-such as enlargement in the aorta, the principal artery responsible for carrying blood from the heart through the chest and torso. Factors such as certain medical conditions, genetic issues, and increased pressure can contribute to the weakening of the aorta, leading to the formation of an aneurysm. These aneurysms may take on a tube-shaped or round structure.

The primary types of aortic aneurysms include thoracic aortic aneurysm (TAA) and abdominal aortic aneurysm (AAA). Thoracic aortic aneurysm (TAA) specifically occurs in the chest region due to a weakened area in the aorta. Various treatments are available, including open surgical repair (OSR) and endovascular aneurysm repair (EVAR), and these are commonly administered in hospitals, clinics, ambulatory surgery centers (ASCS), and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The aortic aneurysm market research report is one of a series of new reports from The Business Research Company that provides aortic aneurysm market statistics, including aortic aneurysm industry global market size, regional shares, competitors with a aortic aneurysm market share, detailed aortic aneurysm market segments, market trends and opportunities, and any further data you may need to thrive in the aortic aneurysm industry. This aortic aneurysm market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aortic aneurysm market size has grown strongly in recent years. It will grow from $3.74 billion in 2024 to $4.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to the aging population, the prevalence of cardiovascular diseases, improvements in diagnostic technologies, surgical advancements, and awareness programs.

The aortic aneurysm market size is expected to see rapid growth in the next few years. It will grow to $5.98 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to a rising global aging population, increased incidence of cardiovascular diseases, advancements in treatment modalities, genetic predisposition awareness, and healthcare infrastructure development. Major trends in the forecast period include the development of next-generation stent grafts, technological integration for remote monitoring, the prevalence of abdominal aortic aneurysms (AAA), and collaborations in research and development.

The forecast of 10.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. vascular surgery by driving up the cost of endovascular stent grafts and intravascular ultrasound systems sourced from Italy and Switzerland, exacerbating elective repair delays and increasing cardiovascular department costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in alcohol and tobacco usage is projected to drive the aortic aneurysm market in the future. Both alcohol and nicotine-containing tobacco products are psychoactive substances impacting the body's central nervous system. The increased consumption of these substances stands as a primary contributor to aortic aneurysms. As per a May 2022 report by the World Health Organization (WHO), an international public health agency headquartered in Switzerland, an estimated 3 million deaths annually are attributed to alcohol consumption, while 7 million deaths occur globally due to tobacco use. Moreover, approximately 13.5% of deaths among individuals aged 20-39 are linked to alcohol consumption. In 2021, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, reported that 11.5% of US adults aged 18 or older were current cigarette smokers, amounting to 28.3 million adults. Hence, the increasing prevalence of alcohol and tobacco consumption is a key driver for the growth of the aortic aneurysm market.

The escalating occurrence of cardiovascular diseases is expected to fuel growth in the aortic aneurysm market. Cardiovascular diseases encompass a range of conditions affecting the heart or blood vessels. Devices tailored for aortic aneurysm treatment significantly contribute to managing cardiovascular diseases, especially those involving aortic aneurysms. For instance, data from May 2023 by the World Heart Federation, a non-governmental organization headquartered in Switzerland, indicated that in 2020, cardiovascular diseases led to 18.9 million fatalities, with forecasts indicating a rise to 22.2 million by 2030 and a further increase to 32.3 million by 2050. Consequently, the increasing incidence of cardiovascular diseases serves as a driving force behind the expansion of the aortic aneurysm market.

Technological advancements have become a prominent trend gaining traction in the aortic aneurysm market. Major companies in this sector are developing and implementing innovative technologies to solidify their market position. For example, in June 2024, Medtronic plc, a medical technology company based in Ireland, introduced the Steerant aortic guidewire, a device designed to enhance precision in aortic procedures. This flexible and advanced tool offers improved maneuverability and control during catheterization, allowing clinicians to navigate complex anatomical pathways more effectively and achieve better patient outcomes. Its goal is to reduce procedural time and minimize complications during aortic interventions.

Major companies in the aortic aneurysm market are concentrating on designing and introducing innovative solutions, such as the Stent-Graft System. This medical device is utilized to treat vascular conditions, particularly aneurysms or tears in blood vessels. It combines a stent, which provides structural support, with a graft made of synthetic material that lines the blood vessel. For example, in August 2024, Terumo India, a medical technology company based in India, launched the TREO Abdominal Stent-graft system. TREO is an advanced device specifically designed to treat abdominal aortic aneurysms, merging a durable stent with a biocompatible graft to offer effective support and reduce the risk of rupture. This system aims to improve patient outcomes by enabling minimally invasive procedures and enhancing long-term stability in vascular interventions.

In May 2023, Striker Corporation, a leading US-based medical technologies firm, completed the acquisition of Cerus Endovascular Ltd. for an undisclosed sum. This strategic acquisition is part of Striker Corporation's efforts to enhance its global portfolio of aneurysm treatment solutions. Cerus Endovascular Ltd., based in the UK, is a medical device company specializing in providing advanced solutions for the treatment of aneurysms.

Major companies operating in the aortic aneurysm market include Cardiatis SA, Cook Medical Inc., Endologix LLC, W L Gore & Associates Inc., JOTEC GmbH, Lombard Medical Limited., Medtronic plc, Terumo Corporation, MicroPort Scientific Corporation, Boston Scientific Corporation, Endospan Ltd., LifeTech Scientific Corporation, B. Braun Melsungen AG, EndoEvolution LLC, CryoLife Inc., Intuitive Surgical Inc., Synovis Micro Companies Alliance Inc., Meril Life Sciences Pvt. Ltd., Vitalitec International GmbH, Getinge AB, CONMED Corporation, Becton, Dickinson and Company, Baxter International Inc., Johnson & Johnson Services Inc., Cardinal Health Inc., TriVascular Technologies Inc., Vascutek Ltd., Aptus Endosystems Inc., Bolton Medical Inc., EndoVascular Technologies Inc., Endurant Energy LLC, LeMaitre Vascular Inc.

North America was the largest region in the aortic aneurysm market in 2024. The regions covered in the aortic aneurysm market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the aortic aneurysm market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The aortic aneurysm market includes revenues earned by entities by open surgery and endovascular repair. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aortic Aneurysm Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aortic aneurysm market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for aortic aneurysm ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The aortic aneurysm market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Aortic Aneurysm Market Characteristics

3. Aortic Aneurysm Market Trends And Strategies

4. Aortic Aneurysm Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Aortic Aneurysm Growth Analysis And Strategic Analysis Framework

6. Aortic Aneurysm Market Segmentation

7. Aortic Aneurysm Market Regional And Country Analysis

8. Asia-Pacific Aortic Aneurysm Market

9. China Aortic Aneurysm Market

10. India Aortic Aneurysm Market

11. Japan Aortic Aneurysm Market

12. Australia Aortic Aneurysm Market

13. Indonesia Aortic Aneurysm Market

14. South Korea Aortic Aneurysm Market

15. Western Europe Aortic Aneurysm Market

16. UK Aortic Aneurysm Market

17. Germany Aortic Aneurysm Market

18. France Aortic Aneurysm Market

19. Italy Aortic Aneurysm Market

20. Spain Aortic Aneurysm Market

21. Eastern Europe Aortic Aneurysm Market

22. Russia Aortic Aneurysm Market

23. North America Aortic Aneurysm Market

24. USA Aortic Aneurysm Market

25. Canada Aortic Aneurysm Market

26. South America Aortic Aneurysm Market

27. Brazil Aortic Aneurysm Market

28. Middle East Aortic Aneurysm Market

29. Africa Aortic Aneurysm Market

30. Aortic Aneurysm Market Competitive Landscape And Company Profiles

31. Aortic Aneurysm Market Other Major And Innovative Companies

32. Global Aortic Aneurysm Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aortic Aneurysm Market

34. Recent Developments In The Aortic Aneurysm Market

35. Aortic Aneurysm Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기